meet the press., page-6

I imagine Elixia would do very well in the US although I'd much prefer it to be done in partnership with a well-established major player. IMO it's the best course of action for max profits and should include a nice upfront - enough to get oxy through to commercialization.

Phusion Labs OTC - I understand, will be smoking cessation and skin/acne products. These are both huge additional markets in their own right.

From my last discussions with POH management at the AGM I believe products are under development.

Apologies for reposting old news I got back yesterday and it'll take me a couple of days to get up to speed.

Good recent defibrillating announcement and voilá once again our shareprice has a heartbeat.